Genscript Biotech Corporation
GNNSF | OTC
$4.50
+$0.12 (+2.74%)
Nov 2, 2026, 10:19 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Dec 31, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -574.2M | -470.53M | -25.46M | -175.12M | -177.01M | -95.48M | -184.93M | -226.85M | -403.1M | -358.71M | -182.98M |
Depreciation & Amortization | 79.5M | 74.04M | 34.89M | 40.3M | 78.82M | 74.05M | 66.69M | 61.18M | 52.88M | 45.86M | 41.29M |
Stock-Based Compensation | 5.22M | 14.79M | 9.58M | 53.35M | 75.08M | 60.59M | 67.56M | 65.15M | 61.63M | 39.69M | 24.69M |
Other Working Capital | 15.37M | 97.71M | 69.72M | 14.81M | 11.36M | -29.74M | 75.84M | 113.59M | 140.1M | 144.6M | 53.05M |
Other Non-Cash Items | 677.23M | 709.05M | 213.61M | 68.15M | 4.54M | -175.42M | -235.03M | -151.91M | 19.24M | 5.33M | -10.23M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -9M | -26.58M | -78.31M | -27.94M | -26.13M | 18.94M |
Change in Working Capital | -38.16M | 68.05M | 69.87M | 93.18M | -1.32M | -150.65M | 40.24M | 132.13M | 106.41M | 131.04M | 9.42M |
Operating Cash Flow | 149.59M | 325.52M | 232.62M | 79.86M | -19.89M | -286.91M | -245.46M | -120.29M | -162.93M | -136.79M | -117.81M |
Capital Expenditures | -99.29M | -83.84M | -32.13M | -134.03M | -306.28M | -252.45M | -222.39M | -216.11M | -138.21M | -133.04M | -132.5M |
Cash Acquisitions | -8.32M | -8.47M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -1.97B | -1.16B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 1.95B | 1.1B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 55.88M | -17.74M | -66.52M | -999.03M | -729.96M | -105.28M | -338.58M | -227.18M | -242.29M | -79.5M | -24.72M |
Investing Cash Flow | -73.16M | -171.95M | -98.65M | -1.13B | -1.04B | -357.73M | -560.97M | -443.3M | -380.5M | -212.55M | -157.21M |
Debt Repayment | 77.95M | 85.73M | n/a | -22.27M | -22.27M | -2.4M | -2.4M | 3.46M | 3.46M | -27.81M | -27.81M |
Common Stock Repurchased | -225.14M | -225.14M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 182.41M | 213.65M | 26.4M | 27.83M | 76.07M | 1.07B | 1.43B | 415.86M | 373.92M | 929.96M | 548.74M |
Financial Cash Flow | -183.5M | -144.89M | 26.4M | 5.57M | 53.81M | 1.07B | 1.43B | 419.32M | 377.38M | 902.14M | 520.93M |
Net Cash Flow | -105.62M | 142.49M | -106.09M | n/a | 448.37M | 422.4M | 615.09M | -156.97M | -175.37M | 551.91M | 250.92M |
Free Cash Flow | 50.3M | 241.69M | 200.49M | -54.17M | -326.16M | -539.36M | -467.85M | -336.41M | -301.15M | -269.83M | -250.31M |
Adj. Free Cash Flow | 45.08M | 226.89M | 190.92M | -107.52M | -401.24M | -599.95M | -535.41M | -401.56M | -362.78M | -309.53M | -274.99M |
Maintenance CapEx | -40.35M | -134.03M | -173.11M | -173.11M | -265.56M | -133.86M | -128.95M | -144.98M | -60.82M | -82.82M | -83.31M |
Growth CapEx | -91.06M | -83.84M | -165.29M | -213.36M | -263.1M | -334.7M | -231.64M | -204.17M | -209.88M | -172.1M | -163.86M |
Owner Earnings | 341.85M | 271.35M | 39.62M | -380.17M | -530.92M | -541.06M | -537.35M | -402.07M | -341.57M | -370.7M | -146.91M |
Add to Watchlist
Select watchlists to add or remove GNNSF